{
    "clinical_study": {
        "@rank": "33477", 
        "arm_group": [
            {
                "arm_group_label": "Reduced Nicotine Content Cigarettes", 
                "arm_group_type": "Experimental", 
                "description": "the experimental group will smoke cigarettes with Gradually Reduced Nicotine Content (RNC) (8 [9 for menthol], 4, 1.7, 0.9 and 0.3 mg) cigarettes, each smoked for 4 weeks, except for the last period which will last 8 weeks to evaluate a longer-term adherence to the lowest nicotine content cigarette."
            }, 
            {
                "arm_group_label": "Same Nicotine Content Cigarettes", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The Same Nicotine Control Group (SNC) will continue to smoke research cigarettes approximately matching the nicotine content of their preferred brand of cigarettes (about 11.4 mg)"
            }
        ], 
        "brief_summary": {
            "textblock": "The overall goal of this study is to address the question of whether progressively lowering\n      nicotine content in cigarettes can reduce or eliminate nicotine dependence in smokers of low\n      socioeconomic status"
        }, 
        "brief_title": "Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status", 
        "completion_date": {
            "#text": "October 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Tobacco Dependence", 
        "condition_browse": {
            "mesh_term": "Tobacco Use Disorder"
        }, 
        "detailed_description": {
            "textblock": "To address the question of whether progressively lowering nicotine content in cigarettes can\n      reduce or eliminate nicotine dependence in low socioeconomic smokers, we will randomize\n      smokers to either an Reduced Nicotine Content group with a gradual step-wise reduction in\n      nicotine from 11 mg to 0.3 mg per cigarette in five 4-wk stages, or a control group with\n      nicotine content that approximately matches the nicotine content of their usual brand of\n      cigarettes.\n\n      Overall, we hypothesize that low socioeconomic smokers who switch to progressively lower\n      nicotine cigarettes will initially alter their smoking behavior to compensate for lower\n      nicotine until cigarette nicotine yields become so low that complete compensation becomes\n      too difficult. At that point, smokers will either drop-out or continue to smoke the reduced\n      nicotine content cigarettes but with incomplete compensatory behaviors."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18-65\n\n          -  Less than 16 years of education\n\n          -  Able to understand, and sign consent\n\n          -  Smoke >4 cigarettes/day for at least a year\n\n          -  No quit attempt in prior 3 months and not planning to quit smoking within next 6\n             months\n\n          -  Plan to live in local area for next 8 months\n\n          -  Able to read and write in English\n\n          -  Women not pregnant and taking steps to avoid pregnancy\n\n        Exclusion Criteria:\n\n          -  College graduate\n\n          -  Use of psychotropic drugs\n\n          -  Significant medical condition, or immune system disorders, respiratory diseases,\n             kidney or liver diseases or any other medical disorders that may affect biomarker\n             data\n\n          -  Use of any non-cigarette nicotine delivery product in the past week or smoking\n             cessation medicine in prior 3 months\n\n          -  Currently pregnant or nursing\n\n          -  Uncontrolled serious psychotic illness or substance abuse\n\n          -  History of difficulties providing blood samples-fainting, poor veins, anxiety"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01928719", 
            "org_study_id": "43804UG-P1", 
            "secondary_id": "1P50DA036107-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Reduced Nicotine Content Cigarettes", 
                "description": "Cigarettes contain 8 [9 for menthol], 4, 1.7, 0.9 and 0.3 mg of nicotine", 
                "intervention_name": "Reduced Nicotine Content Cigarettes", 
                "intervention_type": "Drug", 
                "other_name": "Nicotine"
            }, 
            {
                "arm_group_label": "Same Nicotine Content Cigarettes", 
                "description": "about 11.4 mg nicotine per cigarette", 
                "intervention_name": "Same Nicotine Content Cigarettes", 
                "intervention_type": "Drug", 
                "other_name": "Nicotine"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Smoking", 
            "Nicotine"
        ], 
        "lastchanged_date": "August 26, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20052"
                    }, 
                    "name": "George Washington University School of Public Health"
                }, 
                "investigator": {
                    "last_name": "Kimberly Horn, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hershey", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "17033"
                    }, 
                    "name": "Penn State College of Medicine"
                }, 
                "investigator": {
                    "last_name": "Joshua Muscat, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status", 
        "other_outcome": {
            "description": "Positive and Negative Affect Scale (PANAS): 20-item Likert scale that measures positive states (attentive, interested, alert, excited, enthusiastic, inspired, proud, determined, strong and active) and negative states (distressed, upset, hostile, irritable, scared, afraid, ashamed, guilty, nervous, and jittery)\nSalivary Cortisol and amylase:\nCortisol is produced by the hypothalamic-pituitary-adrenal axis (HPA) axis in response to stress. Salivary alpha amylase (sAA) is a marker of activity for the sympathetic nervous system and has been proposed as a sensitive biomarker for stress-related changes in the body", 
            "measure": "Stress reduction --PANAS, cortisol and amylase", 
            "safety_issue": "No", 
            "time_frame": "Monthly for 6 months"
        }, 
        "overall_contact": {
            "email": "sveldheer@psu.edu", 
            "last_name": "Susan Veldheer, MS", 
            "phone": "717-531-5625"
        }, 
        "overall_contact_backup": {
            "email": "shrabovsky@psu.edu", 
            "last_name": "Shari Hrabovsky, MSN", 
            "phone": "717-531-0003", 
            "phone_ext": "289572"
        }, 
        "overall_official": [
            {
                "affiliation": "Penn State College of Medicine", 
                "last_name": "Joshua Muscat, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "George Washington University School of Public Health", 
                "last_name": "Kimberly Horn, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Progressively lowering nicotine exposure may lead to lower levels of Nicotine metabolites and nicotine derived 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol), and no changes in cigarettes per day and levels of r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (PheT)", 
            "measure": "Urinary nicotine metabolites", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01928719"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Milton S. Hershey Medical Center", 
            "investigator_full_name": "Jonathan Foulds", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Possible predictors of dropout/relapse include smoking topography and expired carbon monoxide, a higher baseline nicotine dependence behavioral score and rapid nicotine metabolism phenotypes", 
            "measure": "Participant dropout/relapse", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Milton S. Hershey Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Milton S. Hershey Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}